Cambrios Technologies Corp. Secures Funding For Bio-Directed Materials Platform And Hires CEO

Cambrios Technologies Corp. – formerly Semzyme, Inc. – a pioneer in the development of bio-directed materials for the electronics industry, announced today that it has secured $1.8 million in Series A venture financing. Cambrios also announced that it has hired Michael R. Knapp, Ph.D., an experienced biotechnology entrepreneur, as the company’s president and chief executive officer.

Back to news